Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program.

Delahanty LM, Pan Q, Jablonski KA, Aroda VR, Watson KE, Bray GA, Kahn SE, Florez JC, Perreault L, Franks PW; Diabetes Prevention Program Research Group.

Diabetes Care. 2014 Oct;37(10):2738-45. doi: 10.2337/dc14-0018. Epub 2014 Jul 14.

2.

Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, Barrett-Connor E; Diabetes Prevention Program.

Diabetes Care. 2008 Jul;31(7):1416-21. doi: 10.2337/dc07-2390. Epub 2008 Mar 20.

3.

Effect of weight loss with lifestyle intervention on risk of diabetes.

Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, Hoskin M, Kriska AM, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner J, Venditti B, Wylie-Rosett J.

Diabetes Care. 2006 Sep;29(9):2102-7.

4.

Lifestyle intervention reduces body weight and improves cardiometabolic risk factors in worksites.

Salinardi TC, Batra P, Roberts SB, Urban LE, Robinson LM, Pittas AG, Lichtenstein AH, Deckersbach T, Saltzman E, Das SK.

Am J Clin Nutr. 2013 Apr;97(4):667-76. doi: 10.3945/ajcn.112.046995. Epub 2013 Feb 20.

5.

Early improvement predicts reduced risk of incident diabetes and improved cardiovascular risk in prediabetic Asian Indian men participating in a 2-year lifestyle intervention program.

Nanditha A, Ram J, Snehalatha C, Selvam S, Priscilla S, Shetty AS, Arun R, Godsland IF, Johnston DG, Ramachandran A.

Diabetes Care. 2014 Nov;37(11):3009-15. doi: 10.2337/dc14-0407. Epub 2014 Sep 11.

PMID:
25216506
6.

Cardiometabolic risk after weight loss and subsequent weight regain in overweight and obese postmenopausal women.

Beavers DP, Beavers KM, Lyles MF, Nicklas BJ.

J Gerontol A Biol Sci Med Sci. 2013 Jun;68(6):691-8. doi: 10.1093/gerona/gls236. Epub 2012 Nov 26.

7.

Weight change and duration of overweight and obesity in the incidence of type 2 diabetes.

Wannamethee SG, Shaper AG.

Diabetes Care. 1999 Aug;22(8):1266-72.

8.

Lifestyle intervention in overweight individuals with a family history of diabetes.

Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W.

Diabetes Care. 1998 Mar;21(3):350-9.

PMID:
9540015
9.

Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals.

Gaesser GA, Angadi SS, Sawyer BJ.

Phys Sportsmed. 2011 May;39(2):87-97. doi: 10.3810/psm.2011.05.1898. Review.

PMID:
21673488
10.

Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.

Halperin F, Ding SA, Simonson DC, Panosian J, Goebel-Fabbri A, Wewalka M, Hamdy O, Abrahamson M, Clancy K, Foster K, Lautz D, Vernon A, Goldfine AB.

JAMA Surg. 2014 Jul;149(7):716-26. doi: 10.1001/jamasurg.2014.514.

11.

A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.

Heald AH, Knapman H, Nair S, Chambers T, Radford D, Rushton T, Anderson SG.

Prim Care Diabetes. 2012 Oct;6(3):213-9. doi: 10.1016/j.pcd.2012.02.002. Epub 2012 May 4.

PMID:
22560663
12.

Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP).

Delahanty LM, Peyrot M, Shrader PJ, Williamson DA, Meigs JB, Nathan DM; DPP Research Group.

Diabetes Care. 2013 Jan;36(1):34-40. doi: 10.2337/dc12-0733. Epub 2012 Nov 5.

13.

Predictors of success of a lifestyle intervention in relation to weight loss and improvement in glucose tolerance among individuals at high risk for type 2 diabetes: the FIN-D2D project.

Rautio N, Jokelainen J, Saaristo T, Oksa H, Keinänen-Kiukaanniemi S; FIN-D2D Writing Group, Peltonen M, Vanhala M, Korpi-Hyövälti E, Moilanen L, Saltevo J, Niskanen L, Tuomilehto J, Uusitupa M.

J Prim Care Community Health. 2013 Jan;4(1):59-66. doi: 10.1177/2150131912444130. Epub 2012 May 14.

PMID:
23799691
14.

Increasing the effectiveness of the Diabetes Prevention Program through if-then plans: study protocol for the randomized controlled trial of the McGill CHIP Healthy Weight Program.

Knäuper B, Ivanova E, Xu Z, Chamandy M, Lowensteyn I, Joseph L, Luszczynska A, Grover S.

BMC Public Health. 2014 May 18;14:470. doi: 10.1186/1471-2458-14-470.

15.

Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).

Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL.

J Am Coll Cardiol. 2011 Jul 5;58(2):140-6. doi: 10.1016/j.jacc.2011.03.025.

16.

The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial.

Katula JA, Vitolins MZ, Morgan TM, Lawlor MS, Blackwell CS, Isom SP, Pedley CF, Goff DC Jr.

Am J Prev Med. 2013 Apr;44(4 Suppl 4):S324-32. doi: 10.1016/j.amepre.2012.12.015.

17.

Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.

Florez H, Temprosa MG, Orchard TJ, Mather KJ, Marcovina SM, Barrett-Connor E, Horton E, Saudek C, Pi-Sunyer XF, Ratner RE, Goldberg RB; Diabetes Prevention Program Research Group.

Diabetes Obes Metab. 2014 Apr;16(4):326-33. doi: 10.1111/dom.12220. Epub 2013 Oct 29.

18.

Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial.

Rock CL, Flatt SW, Pakiz B, Taylor KS, Leone AF, Brelje K, Heath DD, Quintana EL, Sherwood NE.

Diabetes Care. 2014 Jun;37(6):1573-80. doi: 10.2337/dc13-2900. Epub 2014 Apr 23.

19.

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM.

Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. Epub 2009 Oct 29. Erratum in: Lancet. 2009 Dec 19;374(9707):2054.

20.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
Items per page

Supplemental Content

Write to the Help Desk